![Babar Ghias](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Babar Ghias
Finanzdirektor/CFO bei
BIOCRYST PHARMACEUTICALS, INC.
Vermögen: 3 Mio $ am 30.06.2026
Profil
Babar Ghias is currently President & Director at Astria Therapeutics, Inc. since 2026.
Mr. Ghias is Chief Financial Officer at BioCryst Pharmaceuticals, Inc. since 2025.
Mr. Ghias is Chief Operating Officer at Castle Creek Biosciences, Inc. Former positions include Director at MyoTherix, Inc., Chief Financial Officer at AvenCell Therapeutics, Inc., and Vice President-Corporate Development at Marathon Pharmaceuticals LLC.
Education includes an undergraduate degree from Lahore University of Management Sciences and an MBA from Washington University in St. Louis.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.12.2025 | 268.700 ( 0,11 % ) | 3 Mio $ | 30.06.2026 |
Aktive Positionen von Babar Ghias
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 07.07.2025 |
| ASTRIA THERAPEUTICS, INC. | Präsident | 23.01.2026 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Geschäftsführer | - |
Ehemalige bekannte Positionen von Babar Ghias
| Unternehmen | Position | Ende |
|---|---|---|
MyoTherix, Inc.
 MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Direktor/Vorstandsmitglied | - |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for treatment of cancers | Finanzdirektor/CFO | - |
Marathon Pharmaceuticals LLC
 Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Babar Ghias
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Marathon Pharmaceuticals LLC
Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Lahore University of Management Sciences
 Lahore University of Management Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyoTherix, Inc.
MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for treatment of cancers | Health Technology |
